Eli Lilly Launches LillyPod Supercomputer, AI Drug Discovery Enters Era of Pharma-Built Computing Power
In October 2025, Eli Lilly announced plans to build the most powerful supercomputer in the pharmaceu...
SHINE Technologies' Ilumira Lu-177 Receives EU Centralized Marketing Authorization
SHINE Technologies' non-carrier-added lutetium-177 (Lu-177) product, Ilumira, has received a Central...
Novo Nordisk's Wegovy Oral Drug Receives Positive European Review, Plans to Launch in Spain
The European Medicines Agency has issued a positive review for the oral therapy Wegovy (semaglutide)...
The Third Annual Academic Conference of the Beijing Medical Association Nuclear Medicine Specialist Branch in 2026 Convened
The Third Annual Academic Conference of the Beijing Medical Association Nuclear Medicine Specialist ...
Australia's Telix Announces Phase 3 Data for TLX591-Tx at ASCO 2026
Telix Pharmaceuticals Limited presented safety, dosimetry, and pharmacokinetic data from the first p...
French Servier to Acquire US Edgewise Muscular Dystrophy Business for $2.65 Billion, Strengthening Rare Neurological Disease Pipeline
French pharmaceutical group Servier announced on June 1 that it has reached an agreement with US bio...
Belgium's IBA Launches Cyclotron Dedicated to At-211, Bridging the Scale-Up Gap in Targeted Alpha Therapy Supply Chain
Belgian particle accelerator technology company Ion Beam Applications S.A. (IBA) recently launched t...
Shanghe Launches Pharmaceutical Online Inspection Solution with 50mg Accuracy
Shanghe Automation Instrument Equipment (Shanghai) Co., Ltd. has launched a series of online inspect...
Mexico Secures 21 Billion Pesos in Healthcare Investment, Expanding Drug Production and Medical Supply Chains
The Mexican federal government recently announced that pharmaceutical and healthcare companies have ...
France's Abivax Announces Positive Phase III Trial Results for Obefazimod in UC
Abivax announced positive topline results from the Phase 3 ABTECT maintenance trial of its oral miR-...